Description
Galectin-9, Human Recombinant is available at Gentaur for Next week delivery.
A protein strongly overexpressed in Hodgkin's disease tissue.
Biomolecule/Target: Galectin-9
Alternates names: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9
Synonyms: LGALS9, Gal-9, Tumor antigen HOM-HD-21, Ecalectin, Galectin 9, Galectin-9
Background Information: Galectin-9 (Gal-9) is a member of animal lectins that have an affinity to beta-galactosides and Forssman pentasaccharide. It is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. Recombinant Galectin-9 protein was expressed in E.coli and purified by using conventional chromatography techniques.
Reconstitution Instructions: N/A
NCBI Gene Symbol: LGALS9
Gene ID: 3965
NCBI Accession: O00182
Additional Information
Size: |
50 μg |
Country of Manufacturing Origin: |
USA |
Country of Animal Origin: |
USA |
Gene Source: |
Human |
Recombinant: |
Yes |
Source: |
E. coli |
Purity by SDS-PAGE: |
≥90% |
Assay: |
SDS-PAGE |
Purity: |
N/A |
Assay 2: |
N/A |
Endotoxin Level: |
N/A |
Activity (Specifications/test method): |
N/A |
Biological activity: |
The ED50 for this effect is equal to or less than 2.5 µg/ml. Measured by its ability to agglutinate human red blood cells. |
Results: |
N/A |
Molecular Weight: |
18.5 kDa (168 aa, 1-148 aa + His Tag). |
Storage Temperature: |
Mutiple |
Shelf Life: |
12 months |
Concentration: |
0.5 mg/ml |
Appearance: |
Liquid |
Handling: |
Centrifuge the vial prior to opening. |